- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Immobilier
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 172 results
Webinar
décembre 18, 2024
Changed Landscape? How 2024 Elections Will Impact Healthcare M&A
Webinar
décembre 4, 2024
Fundamentals of EU Pharmaceutical Law
Webinar
novembre 28, 2024
Virtual Talk im Turm: Health Claims in Advertising Botanicals (ECJ Case C-386/23)
Webinar
novembre 27, 2024
Virtual Talk im Turm: EU Regulation on “Green Claims” – How to Ensure Compliance
Webinar
novembre 14, 2024
A Provider’s Guide to Information Blocking: Where We Are Now and What to Expect in 2025
Webinar
octobre 24, 2024
Real-World Data for Clinical Trials: Brand New FDA Expectations for Use of Real-World Evidence for Regulatory Decision-Making
Webinar
septembre 19, 2024
Hot Topics in Behavioral Healthcare
Webinar
septembre 18, 2024
Addressing Misinformation: Insights on Social Media and Influencer Marketing
Webinar
août 21, 2024
Managing New and Emerging Data Privacy and Security Risks for U.S. and EU Life Sciences Companies
Webinar
juillet 18, 2024
Talk im Turm: Update on Regulation of Remuneration in Investment Firms